Ayala Pharmaceuticals Inc (ADXS)

[mm2k]

Why can't you accept that AMGN might have simply changed their priorities, or decided that other investments might be better short term business opportunities? You could probably even make a case that they didn't like the way the NEO program was managed by ADXS, but to say it was based on preliminary NEO clinical data (for the Nth time) is really getting old and unsupported by the facts.